Delisted from NASDAQ in Sep 2023
CFMS - Conformis, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Billerica,
United States
Type: Equity
CFMS price evolution
CFMS
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 | 30 Oct 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $26.64 | $38.25 | $49.13 | $60.04 |
| Short term investments | ||||
| Net receivables | $7.8 | $8.67 | $9.91 | $9.61 |
| Inventory | $19.02 | $19.49 | $18.91 | $18.02 |
| Total current assets | $54.62 | $67.62 | $79.27 | $88.81 |
| Long term investments | ||||
| Property, plant & equipment | $12.61 | $13.76 | $14.23 | $15.24 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $13.16 | $14.3 | $14.78 | $15.79 |
| Total investments | ||||
| Total assets | $67.78 | $81.92 | $94.05 | $104.59 |
| Current liabilities | ||||
| Accounts payable | $3.58 | $4.16 | $4.16 | $6.56 |
| Deferred revenue | ||||
| Short long term debt | $1.94 | $1.95 | $1.93 | $1.92 |
| Total current liabilities | $10.77 | $11.84 | $14.07 | $17.52 |
| Long term debt | $24.65 | $25.17 | $20.56 | $25.91 |
| Total noncurrent liabilities | $24.98 | $25.46 | $25.8 | $25.91 |
| Total debt | $26.58 | $27.13 | $27.5 | $27.83 |
| Total liabilities | $35.76 | $37.3 | $39.87 | $43.43 |
| Shareholders' equity | ||||
| Retained earnings | -$603.91 | -$590.89 | -$581.32 | -$577.61 |
| Other shareholder equity | $0.23 | $0.25 | $0.86 | $3.88 |
| Total shareholder equity | $32.02 | $44.63 | $54.18 | $61.16 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $49.13 | $101.12 | $29.14 | $26.86 |
| Short term investments | ||||
| Net receivables | $9.91 | $9.36 | $9.77 | $11.23 |
| Inventory | $18.91 | $15.2 | $12.59 | $12.07 |
| Total current assets | $79.27 | $126.88 | $53.34 | $52.51 |
| Long term investments | ||||
| Property, plant & equipment | $14.23 | $17.8 | $17.45 | $19.21 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $14.78 | $18.46 | $18.16 | $19.88 |
| Total investments | ||||
| Total assets | $94.05 | $145.34 | $71.5 | $72.4 |
| Current liabilities | ||||
| Accounts payable | $4.16 | $6.56 | $4.92 | $6.92 |
| Deferred revenue | ||||
| Short long term debt | $1.93 | $1.83 | $1.62 | $1.47 |
| Total current liabilities | $14.07 | $17.96 | $30.92 | $17.86 |
| Long term debt | $20.56 | $26.83 | $29.21 | $24.69 |
| Total noncurrent liabilities | $25.8 | $26.83 | $29.21 | $38.19 |
| Total debt | $27.5 | $28.66 | $30.83 | $26.16 |
| Total liabilities | $39.87 | $44.79 | $60.13 | $56.05 |
| Shareholders' equity | ||||
| Retained earnings | -$581.32 | -$530.85 | -$528.44 | -$504.14 |
| Other shareholder equity | $0.86 | -$1.11 | -$4 | -$0.86 |
| Total shareholder equity | $54.18 | $100.55 | $11.37 | $16.35 |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Oct 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $13.02 | $12.84 | $17.42 | |
| Cost of revenue | $11.19 | $7.73 | $10.27 | |
| Gross Profit | $1.83 | $5.1 | $7.16 | |
| Operating activities | ||||
| Research & development | $2.16 | $2.46 | $3.23 | |
| Selling, general & administrative | $11.98 | $12.07 | $10.73 | |
| Total operating expenses | $14.14 | $14.53 | $13.96 | |
| Operating income | -$12.3 | -$9.43 | -$6.8 | |
| Income from continuing operations | ||||
| EBIT | -$12.31 | -$8.95 | -$3.11 | |
| Income tax expense | $0.03 | -$0.02 | $0.02 | |
| Interest expense | $0.67 | $0.64 | $0.59 | |
| Net income | ||||
| Net income | -$13.01 | -$9.57 | -$3.72 | |
| Income (for common shares) | -$13.01 | -$9.57 | -$3.72 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $62.05 | $99.86 | $68.76 | $77.43 |
| Cost of revenue | $38.84 | $34.18 | $35.05 | $40.69 |
| Gross Profit | $23.21 | $65.68 | $33.72 | $36.74 |
| Operating activities | ||||
| Research & development | $15.34 | $14.79 | $11.94 | $12.46 |
| Selling, general & administrative | $54.15 | $53.9 | $46.89 | $49.41 |
| Total operating expenses | $69.49 | $68.69 | $58.83 | $61.87 |
| Operating income | -$46.28 | -$3.01 | -$25.11 | -$25.13 |
| Income from continuing operations | ||||
| EBIT | -$48.48 | $1.17 | -$21.88 | -$25.49 |
| Income tax expense | -$0.02 | $0.09 | $0.04 | $0.04 |
| Interest expense | $2.02 | $3.5 | $2.37 | $2.94 |
| Net income | ||||
| Net income | -$50.47 | -$2.41 | -$24.29 | -$28.48 |
| Income (for common shares) | -$50.47 | -$2.41 | -$24.29 | -$28.48 |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Net income | -$13.01 | -$9.57 | -$3.72 | -$15.2 |
| Operating activities | ||||
| Depreciation | $1.31 | $1.3 | $1.33 | $1.34 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.43 | $0.62 | -$0.25 | $0.8 |
| Total cash flows from operations | -$11.29 | -$9.85 | -$11.36 | -$12.03 |
| Investing activities | ||||
| Capital expenditures | -$0.31 | -$0.91 | -$0.32 | -$0.61 |
| Investments | ||||
| Total cash flows from investing | -$0.31 | -$0.91 | -$0.32 | -$0.61 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | -$0.01 | -$0.13 | $0.77 | -$0.42 |
| Change in cash and equivalents | -$11.6 | -$10.88 | -$10.91 | -$13.06 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$50.47 | -$2.41 | -$24.29 | -$28.48 |
| Operating activities | ||||
| Depreciation | $5.55 | $5.72 | $5.55 | $5.38 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.13 | $3.81 | $3.41 | $2.84 |
| Total cash flows from operations | -$50.15 | -$8.4 | -$18.31 | -$2.84 |
| Investing activities | ||||
| Capital expenditures | -$1.92 | -$2.3 | -$3.25 | -$2.93 |
| Investments | $7.25 | |||
| Total cash flows from investing | -$1.92 | -$2.3 | -$3.25 | $4.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $84.89 | $19.05 | $5.18 | |
| Net borrowings | -$0.87 | $4.71 | $4.26 | |
| Total cash flows from financing | $82.8 | $23.76 | $8.53 | |
| Effect of exchange rate | $0.08 | -$0.12 | $0.08 | $0 |
| Change in cash and equivalents | -$51.99 | $71.98 | $2.28 | $10.01 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 7.88M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -14.85% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 4.04 |
| Cash/Share | 3.38 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.74 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 5.07 |
| Quick ratio | 3.30 |